Filing Flows › IDEX (IEX) › Health & Science Technologies revenue
IDEX (IEX) Health & Science Technologies revenue by quarter
IDEX's Health & Science Technologies revenue was $432M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 7 quarters it ranged from $340M (Q1 2025) to $432M (Q3 2026).
| Quarter | Health & Science Technologies revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $432M | +4% | +14% |
| Q2 2026 | $414M | +4% | +14% |
| Q1 2026 | $397M | -2% | +17% |
| Q4 2025 | $407M | +7% | — |
| Q3 2025 | $380M | +4% | — |
| Q2 2025 | $364M | +7% | — |
| Q1 2025 | $340M | — | — |
Q3 2026 at a glance
IDEX, Q3 2026: revenue $952M (+8% year over year), operating margin 21.9%, net earnings $144M, operating cash flow $240M. The chart follows the revenue to costs, profit and cash.
Questions
What is IDEX's Health & Science Technologies revenue?
IDEX's Health & Science Technologies revenue was $432M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has IDEX's Health & Science Technologies revenue changed?
Over the last 7 quarters it ranged from $340M (Q1 2025) to $432M (Q3 2026).